Jijun Wang Selected Research

Sulpiride (neogama)

4/2014	Sulpiride versus placebo for schizophrenia.
3/2010	Sulpiride augmentation for schizophrenia.
1/2010	Sulpiride augmentation for schizophrenia.
4/2009	Sulpiride versus placebo for schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jijun Wang Research Topics

Disease

73	Schizophrenia (Dementia Praecox) 10/2022 - 11/2003
21	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 04/2005
9	Neoplasms (Cancer) 01/2020 - 04/2014
6	Cognitive Dysfunction 01/2021 - 10/2014
5	Mental Disorders (Mental Disorder) 01/2022 - 04/2009
5	Anxiety Disorders (Anxiety Disorder) 01/2020 - 02/2015
4	Major Depressive Disorder (Major Depressive Disorders) 12/2021 - 01/2018
4	Inflammation (Inflammations) 05/2021 - 01/2018
3	Atrophy 05/2021 - 01/2018
3	Insulin Resistance 03/2018 - 12/2012
2	Flushing 01/2022 - 01/2018
2	Hallucinations (Hallucination) 01/2020 - 08/2013
2	Panic Disorder (Panic Attack) 01/2020 - 09/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 03/2016
2	Lymphoma (Lymphomas) 01/2018 - 10/2016
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 02/2015 - 10/2010
1	Dyslipidemias (Dyslipidemia) 01/2022
1	COVID-19 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Burns 05/2021
1	Cerebral Cortical Thinning 01/2021
1	Prodromal Symptoms 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Treatment-Resistant Depressive Disorder 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Cataplexy 01/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 09/2018
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 03/2018
1	Non-alcoholic Fatty Liver Disease 03/2018

Drug/Important Bio-Agent (IBA)

31	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 04/2005
25	Pharmaceutical PreparationsIBA 01/2022 - 11/2003
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2012
6	salicylhydroxamic acid (SHAM)IBA 10/2022 - 06/2012
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 10/2012
4	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 01/2018
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2020 - 01/2018
4	gamma-Aminobutyric Acid (GABA)IBA 12/2018 - 12/2014
4	Sulpiride (neogama)IBA 04/2014 - 04/2009
3	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2022 - 01/2018
3	Biological ProductsIBA 01/2022 - 01/2018
3	Citalopram FDA LinkGeneric 05/2021 - 01/2019
3	Aminobutyrates (Aminobutyric Acid)IBA 12/2018 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2018 - 04/2015
3	Clozapine (Clozaril)FDA LinkGeneric 12/2016 - 01/2010
2	sulforaphaneIBA 01/2022 - 01/2021
2	CholesterolIBA 01/2022 - 03/2018
2	NucleotidesIBA 11/2021 - 10/2018
2	ProlactinIBA 11/2021 - 01/2010
2	Aripiprazole (Abilify)FDA Link 05/2021 - 02/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2020
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 06/2019 - 11/2015
2	Protons (Proton)IBA 12/2018 - 05/2016
2	Insulin (Novolin)FDA Link 03/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2018
2	Cholinergic ReceptorsIBA 12/2016 - 11/2016
2	Nicotine FDA Link 12/2016 - 01/2014
2	N-acetylaspartate (N-acetyl aspartate)IBA 05/2016 - 10/2010
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	1-stearoyl-2-arachidonoylglycerolIBA 01/2022
1	Zolpidem (Ambien)FDA LinkGeneric 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 11/2021
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 11/2021
1	16S Ribosomal RNAIBA 10/2021
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 08/2021
1	ElectrolytesIBA 05/2021
1	Nifedipine (Adalat)FDA LinkGeneric 01/2021
1	TESIBA 01/2021
1	valylvaline (Val-Val)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	Dopamine D3 ReceptorsIBA 01/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020
1	Particulate MatterIBA 01/2020
1	propylene diquat (PDQ(+))IBA 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2019
1	CytokinesIBA 10/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Neuroprotective AgentsIBA 09/2018
1	neohesperidinIBA 09/2018
1	oxidized low density lipoproteinIBA 03/2018
1	Alanine Transaminase (SGPT)IBA 03/2018
1	LDL CholesterolIBA 03/2018
1	Triglycerides (Triacylglycerol)IBA 03/2018

Therapy/Procedure

9	Transcranial Magnetic Stimulation 01/2021 - 08/2013
7	Therapeutics 01/2022 - 11/2007
3	Drug Therapy (Chemotherapy) 01/2020 - 04/2014
2	Transcranial Direct Current Stimulation 10/2022 - 01/2021
2	Aftercare (After-Treatment) 01/2022 - 12/2018
2	Transplantation 01/2018 - 01/2015
1	Precision Medicine 12/2021
1	Hematopoietic Stem Cell Transplantation 01/2019